CD4 and neoplasm: CD8+ independent prognostic factor for OS. High levels of CD3+, CD4+, CD8, and CD45R0 TILs correlate with better DFS. Higher level of TILs (CD3+, CD4+, CD8+, and CD45R0+) associated with tumor response after neoadjuvant chemotherapy